HPV Vaccine: Debunking Myths and Protecting Against Cancer in Brazil and Beyond
Despite being a crucial tool in the fight against various cancers, the HPV vaccine remains shrouded in misinformation. Common rumors – ranging from claims it encourages early sexual activity to fears of serious side effects like infertility – have no scientific basis and actively hinder vaccination efforts.
The human papillomavirus (HPV) is often asymptomatic, yet it’s responsible for a range of severe illnesses, including cancers of the cervix, penis, anus, and oropharynx. In Brazil, the impact is particularly stark. Data from the National Cancer Institute (INCA) estimates 17,000 new cases and 7,209 deaths from cervical cancer annually, making it the second leading cause of cancer death among women in the country. Penile cancer, while representing 2% of all cancer cases in Brazil, is more prevalent in the North and Northeast regions, according to the Ministry of Health.
Currently, the HPV vaccine is freely available in Brazil for girls and boys aged 9 to 19, and for priority groups – including individuals with compromised immune systems and survivors of sexual violence – up to age 45. However, widespread fear fueled by misinformation continues to deter many from vaccinating their children.
Addressing Vaccine Resistance: Separating Fact from Fiction
Vaccine hesitancy often stems from a lack of accurate information. A leading pediatrician and medical manager at the Butantan Institute stated, “There is no scientific evidence that proves the HPV vaccine has any relationship with the early onset of sexual activity. On the contrary, it is a form of protection against serious diseases, such as cancer, which can affect people’s adult lives.”
Another pervasive myth centers on the vaccine causing cancer. “The vaccine not only prevents cancer, it also protects against types of HPV that are directly linked to the development of cancer, such as cervical and penile cancer,” the expert explained. The vaccine utilizes Virus-Like Particles (VLPs), which lack genetic material and are therefore incapable of causing infection or cancer.
Concerns about safety for children and adolescents are also unfounded. “The immune response is stronger between 9 and 14 years old. This makes the vaccine more effective in this age group. It is largely safe, with more than 15 years of studies proving its effectiveness,” the pediatrician affirmed. The HPV vaccine has been approved by Brazil’s National Health Surveillance Agency (Anvisa) and included in the National Vaccination Calendar since 2014.
Confirmed Safety and Efficacy: Dispelling Further Fears
Many individuals express anxieties about serious side effects, such as seizures or infertility. However, studies consistently demonstrate that these effects are exceedingly rare. According to the expert, “There is no evidence to suggest that the vaccine causes infertility or serious neurological reactions. On the contrary, it is a way to prevent much more serious complications, such as cancer, which can compromise reproductive health.”
Recent fears surrounding thrombosis or blood clots have also been thoroughly investigated. “Large-scale studies, such as the one carried out in Denmark with 500,000 women, found no relationship between the HPV vaccine and an increase in thrombosis,” the pediatrician highlighted.
The Importance of Universal Vaccination: Protecting Everyone
A common misconception is that the HPV vaccine is solely for women. This is demonstrably false. HPV is responsible for cancers of the penis, anus, and oropharynx, in addition to genital warts. A 2023 study published in The Lancet Global Health revealed that one in three men over the age of 15 is infected with at least one type of genital HPV, with a significant proportion of these infections being high-risk.
Vaccinating boys is not only crucial for their individual health but also contributes to reducing the overall spread of the virus and lowering the risk of cancer within the community. “Vaccinating boys and girls is a collective strategy that can change the reality of HPV-associated cancer in the future,” the pediatrician concluded.
